About XSensor PPG™

Introducing XSensor PPG™

XSensor PPG™ provides real-time monitoring and assessment of the total pharmacodynamic (PD) impact of drug delivery on the patient's well-being. The system monitors the physiological effects of a patient's drug regimen on their cardiopulmonary status. In addition to the commonly monitored vital signs such as heart rate and oxygen saturation, XSensor PPG™ measures respiratory rate and analyzes photoplethysmography (PPG) signals for hypopnea, central and obstructive apnea, and trends these values to determine the degree of respiratory depression and respiratory "effort". Because these measurements are obtained from sensors at a "single point of contact" (SPOC) on the nasal ala, surrogates for cerebral blood flow and venous capacitance can be measured. 

From the central alar source, the XSensor PPG™ provides real-time heart rate, oxygen saturation, respiration rate, respiratory effort, and respiratory obstruction index. The system directly monitors the PD effects of all the factors that may contribute to hypopnea and apnea, and monitors the combined effects of hypoxemia, opioids, other drugs, and the patient's physiological state. XSensor PPG™ ensures the safest pain medication infusion based on a robust and accurate PD assessment of the patient's respiratory and cardiovascular status.

XSensor PPG™ alerts a healthcare professional immediately if a patient is trending towards respiratory distress or depression, allowing early intervention to prevent respiratory arrest, and it can discontinue medication infusion until a healthcare professional intervenes.